Agilis Biotherapeutics is Biotechnology in United States that focus on based therapeutics business. Founded in 2013. They cover business area such as developer, DNA base therapeutic, life-threatening or fatal rare disease, a correct copy, target cell, long-term efficacy, patient, often fatal, rare genetic disease.
2013
( 11 years old in 2024 )
Based Therapeutics
-
Kendall Square, 245 First Street
Suite 1800
Cambridge, MA 02142
United States
Private
developerDNA base therapeuticlife-threatening or fatal rare diseasea correct copytarget celllong-term efficacypatientoften fatal, rare genetic disease
* We use standard office opening hours in near Agilis Biotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Agilis Biotherapeutics is Biotechnology business from United States that founded in 2013 (11 years old in 2024), Agilis Biotherapeutics business is focusing on Based Therapeutics.
Agilis Biotherapeutics headquarter office and corporate office address is located in Kendall Square, 245 First Street Suite 1800 Cambridge, MA 02142 United States.
Agilis Biotherapeutics was founded in United States.
In 2024, Agilis Biotherapeutics is currently focus on based therapeutics sector.
Above is snippet of Google Trends for "based therapeutics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Agilis Biotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
